Pharmacokinetics of N-desmethyldiazepam after a single oral dose of clorazepate: The effect of smoking
- 1 January 1981
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 21 (3) , 229-233
- https://doi.org/10.1007/bf00627925
Abstract
The pharmacokinetics of N-desmethyl-diazepam was evaluated after oral administration of clorazepate 20 mg to 12 healthy male volunteers (6 smokers; 6 non-smokers), aged 23–29 years. Plasma levels of desmethyldiazepam were measured by gas liquid chromatography. The half life of elimination (t1/2β) was significantly longer in the non-smoking volunteers than in the smokers: 54.7±17.7 versus 29.8±9.9 h (pmax) were higher in non-smokers than in smokers, 413±106 µg/l and 245±50 µg/l, respectively (p<0.05). The sedative effect of clorazepate was less severe in smokers than in non-smokers.Keywords
This publication has 18 references indexed in Scilit:
- Diazepam disposition determinantsClinical Pharmacology & Therapeutics, 1980
- Physiological and psychological effects of clorazepate in man.British Journal of Clinical Pharmacology, 1980
- Role of tobacco smoking in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Pharmacokinetics of N-desmethyldiazepam in healthy volunteers after single daily doses of dipotassium chlorazepatePsychopharmacology, 1977
- Enhanced drug metabolism in cigarette smokers.BMJ, 1976
- Plasma level studies in psychotropic evaluation.British Journal of Clinical Pharmacology, 1976
- The effects of age and liver disease on the disposition and elimination of diazepam in adult man.Journal of Clinical Investigation, 1975
- Clinical and biochemical comparison of clorazepate and diazepamPsychological Medicine, 1974
- Clinical Depression of the Central Nervous System Due to Diazepam and Chlordiazepoxide in Relation to Cigarette Smoking and AgeNew England Journal of Medicine, 1973
- Stimulatory effect of cigarette smoking on the hydroxylation of 3,4‐benzpyrene and the N‐demethylation of 3‐methyl‐4‐monomethylaminoazobenzene by enzymes in human placentaClinical Pharmacology & Therapeutics, 1969